CoreMedica Europe | Intercantonal collaboration on SARS-COV-2 detection in saliva
Share this article
Partnership on the analysis of SARS-COV-2 virus in saliva using the RT-PCR method
CoreMedica Europe a Swiss biotechnology company based in Geneva and the Swiss Integrative Center for Human Health (SICHH), a competence centre based in Fribourg, announced their partnership on the analysis of SARS-COV-2 virus in saliva using the RT-PCR method, destined to both individuals and companies in Switzerland.
This inter-cantonal collaboration between CoreMedica Europe and SICHH aims to provide simple and effective solutions for detecting the virus from saliva samples taken at home or in the workplace and to receive the results electronically or as a paper copy within 24 hours. The simplicity of such sampling does not compromise the quality of the tests carried out in the respective laboratories of the two entities authorised by Swissmedic. The tests are part of the new testing strategy of the Swiss Confederation’s Ordinance 3 COVID-19. The greatest advantage of this approach is that it avoids the need to travel to a testing centre and allows anyone to be tested from their home or workplace.